公司资料
Pfizer, Inc. 股价、新闻与催化剂
- 股票代码:
- PFE
- 交易所:
- NYSE
- 行业:
- Biopharma, Oncology, Vaccines
- 所在地:
- United States
股票表现
26.87 USD (+0.30%)
收盘价
最后更新: 2026年8月17日
146B USD
市值
股价为何变动
As of Aug 17, 2026, PFE closed up 0.30% at $26.87. No new same-company headline was identified in the current news window.
公司概览
业务概览
Pfizer is a global pharmaceutical company spanning vaccines, oncology, inflammation, rare disease, and hospital products. The company’s narrative is now centered on post-COVID portfolio renewal and pipeline execution.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Pfizer has one of the broadest global commercial footprints in healthcare. It sits in large-cap pharma with strong international reach.
商业模式特征
Pfizer depends on product sales, pipeline replacement, lifecycle management, and strategic capital allocation. Investors focus on earnings quality, launch timing, and how effectively the company can rebuild growth after major patent and demand transitions.
生物医药行业定位
Pfizer is a mature large-cap pharma name with enough pipeline and vaccine exposure to retain catalyst sensitivity. It is not a binary biotech stock, but major approvals and portfolio shifts still matter.
未来催化剂
- Pfizer’s near-term catalysts are likely to be post-Seagen oncology execution, selected late-stage pipeline updates, and evidence that the company’s post-COVID revenue mix is getting more stable. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新闻
- 01
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。